| Drug Name: | Alcaftadine (147084-10-4) |
|---|---|
| PubChem ID: | 19371515 |
| SMILES: | CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1 |
| InchiKey: | MWTBKTRZPHJQLH-UHFFFAOYSA-N |
| Therapeutic Category: | Histamine Agents, Histamine Antagonists, Histamine H1 Antagonists, Neurotransmitter Agents |
| Molecular Weight (dalton) | : | 307.397 |
| LogP | : | 2.7792 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 38.13 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Burning Sensation | ADReCS |
| Eye Irritation | ADReCS |
| Eye Pruritus | ADReCS |
| Headache | ADReCS |
| Influenza | ADReCS |
| Instillation Site Pain | ADReCS |
| Nasopharyngitis | ADReCS |
| Ocular Hyperaemia | ADReCS |